GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer
20 janv. 2022 09h50 HE
|
Genomicare Biotechnology
HAVERFORD, Pa., Jan. 20, 2022 (GLOBE NEWSWIRE) -- GenomiCare Biotechnology, a leader in precision medicine of Chinese cancer patients and the application of RWD to pharmaceutical research and...
Real-World Evidence (RWE) Solutions Market Worth $4.4 Billion by 2028 - Exclusive Report by Meticulous Research®
17 nov. 2021 10h45 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 17, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled “RWE Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated],...
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
02 août 2021 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to...
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
03 mai 2021 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
20 avr. 2021 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C. and PALO ALTO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading...
Real-world Evidence (RWE) Solutions Market to Reach $3.13 Billion by 2027, Growing at a CAGR of 16.5%, Says Meticulous Research®
15 mars 2021 08h30 HE
|
Meticulous Market Research Pvt. Ltd.
Redding, California, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Real-world Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application...
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
03 mars 2021 08h45 HE
|
Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
Real-World Evidence (RWE) Solutions Market Worth $3.13 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®
25 nov. 2020 08h30 HE
|
Meticulous Market Research Pvt. Ltd.
London, Nov. 25, 2020 (GLOBE NEWSWIRE) -- According to a new market research report “Real-World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development...
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies
29 juil. 2020 02h00 HE
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies BRUSSELS, BELGIUM. – July...
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement
21 nov. 2019 09h02 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released “Real World Value:...